SANA
Sana Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.30
+1.32%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.22
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12.4%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.15 | -$0.22 | Miss -49.76% | — |
| May 11, 2026 | -$0.15 | -$0.14 | Beat 6.67% | — |
| Mar 3, 2026 | -$0.13 | -$0.16 | Miss -23.08% | — |
| Nov 6, 2025 | -$0.18 | -$0.15 | Beat 16.67% | — |
| May 8, 2025 | -$0.22 | -$0.20 | Beat 9.09% | — |
| Mar 17, 2025 | -$0.25 | -$0.23 | Beat 8.00% | — |
| Nov 8, 2024 | -$0.26 | -$0.25 | Beat 3.85% | — |
| Aug 8, 2024 | -$0.27 | -$0.32 | Miss -18.52% | — |
| Feb 29, 2024 | -$0.37 | -$0.35 | Beat 5.41% | — |
| Aug 3, 2023 | -$0.42 | -$0.45 | Miss -7.14% | — |
| Mar 16, 2023 | -$0.41 | -$0.40 | Beat 2.44% | — |
| Nov 2, 2022 | -$0.39 | -$0.48 | Miss -23.08% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026